Contraindications and Precautions Do NOT use AOD-9604 if you: Are pregnant, trying to conceive, or breastfeeding (no safety data in pregnancy/lactation) Have active cancer or history of malignancy (peptide effects on existing cancer unknown) Are under 18 years of age (pediatric safety not established) Have known hypersensitivity to peptides or benzyl alcohol (in bacteriostatic water) Have severe kidney or liver disease without physician clearance Use with caution and enhanced monitoring if you have: Diabetes or glucose metabolism disorders (monitor blood sugar closely despite no expected impact) Cardiovascular disease (comprehensive cardiac evaluation recommended) Thyroid disorders (monitor thyroid function during therapy) History of migraines (may increase headache frequency in susceptible individuals) Drug Interactions Limited formal drug interaction studies exist for AOD-9604
GHK-Cu peptide 100 mg Research Overview GHK-Cu peptide, also known as the copper peptide, is a naturally occurring research-grade tripeptide complex composed of glycyl-L-histidyl-L-lysine bound to a copper ion
10.1111/j.1872-034X.2008.00419.x 58 LiG.ChenJ
The most commonly reported effects during the initiation phase include: Injection site reactions: Mild redness, itching, or a small bump at the site that resolves within hours
Diuretics and Masking Agents, xipamide was added as an example
DAC (Drug Affinity Complex) binds to albumin in the bloodstream, which dramatically extends the peptide's half-life
